Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

$0.0001 0.00 (0.00%)
As of 08/13/2026 02:02 PM Eastern
Compare

GMVDF vs. SDCCQ, VRAYQ, TTOO, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? G Medical Innovations's main competitors and comparable companies include SmileDirectClub (SDCCQ), ViewRay (VRAYQ), T2 Biosystems (TTOO), Acutus Medical (AFIB), and Minerva Surgical (UTRS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does G Medical Innovations compare to SmileDirectClub?

SmileDirectClub (NASDAQ:SDCCQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

G Medical Innovations has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, indicating that its stock price is 2,841% more volatile than the broader market.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
G Medical Innovations N/A N/A N/A

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
G Medical Innovations Neutral

Summary

G Medical Innovations beats SmileDirectClub on 4 of the 6 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

G Medical Innovations has lower revenue, but higher earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33MN/AN/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

ViewRay has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, indicating that its stock price is 2,841% more volatile than the broader market.

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
G Medical Innovations N/A N/A N/A

In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
ViewRay Neutral
G Medical Innovations Neutral

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to T2 Biosystems?

G Medical Innovations (NASDAQ:GMVDF) and T2 Biosystems (NASDAQ:TTOO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.01-$24.63MN/AN/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

G Medical Innovations has a beta of 29.41, suggesting that its stock price is 2,841% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.75, suggesting that its stock price is 675% more volatile than the broader market.

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 0.0% of T2 Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
T2 Biosystems Neutral

Summary

G Medical Innovations beats T2 Biosystems on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Acutus Medical has a beta of 5.7, meaning that its stock price is 470% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, meaning that its stock price is 2,841% more volatile than the broader market.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
G Medical Innovations N/A N/A N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
G Medical Innovations Neutral

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

Summary

G Medical Innovations beats Acutus Medical on 7 of the 9 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

6.0% of G Medical Innovations shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Minerva Surgical has a beta of 2.41, indicating that its share price is 141% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, indicating that its share price is 2,841% more volatile than the broader market.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
G Medical Innovations Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
G Medical Innovations N/A N/A N/A

G Medical Innovations has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$26K$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E RatioN/A26.22269.0625.28
Price / Sales0.0163.09592.5787.62
Price / CashN/A33.9270.4850.90
Price / BookN/A6.1012.916.24
Net Income-$24.63M$148.67M$3.45B$347.60M
7 Day PerformanceN/A1.84%1.12%1.07%
1 Month PerformanceN/A4.56%1.79%1.03%
1 Year PerformanceN/A8.67%67.69%20.77%

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/A$0.00
flat		N/AN/A$26K$4.42MN/A72
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$16K$102.21MN/A300
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-95.5%$11K$7.68MN/A180
AFIB
Acutus Medical
N/A$0.00
-50.0%		N/A-80.0%$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The Shocking Discovery Investigators Found Hidden Inside America's Port Cranes
U.S. investigators found unexplained cellular modems inside cranes made by a Chinese state-owned company that ...
Altimetry | Sponsoredtc pixel
How a rare metal shortage sent gains up 2512 percent
In 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...
Awesomely | Sponsoredtc pixel